Skip to main content
Clinical Trials/DRKS00033834
DRKS00033834
Recruiting
Not Applicable

Influence of delayed initiation of therapy on the course of disease in hepatocellular carcinoma - Staging in HCC - LMU-RAD01174

MU Klinik und Poliklinik für Radiologie0 sites900 target enrollmentMay 24, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C22
Sponsor
MU Klinik und Poliklinik für Radiologie
Enrollment
900
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 24, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
MU Klinik und Poliklinik für Radiologie

Eligibility Criteria

Inclusion Criteria

  • HCC patients \=18 years
  • \- Presence of multiphasic cross\-sectional imaging (MRI and CT) at initial diagnosis and immediately prior to local therapy
  • \- No additional treatment of HCC prior to local therapy

Exclusion Criteria

  • \- Incomplete or insufficient imaging that impairs correct image interpretation (e.g. due to artifacts or lack of the correct contrast agent phases).

Outcomes

Primary Outcomes

Not specified

Similar Trials